Blood‐cell‐free circulating micro‐RNAs (miRNAs) have been proposed as potential accessible
biomarkers for neurodegenerative diseases such as Parkinson's disease (PD). Here we …

Alzheimer's disease (AD) is the most common neurodegenerative dementia. Approximately
10% of cases present at an age of onset before 65 years old, which in turn can be …

… Author links open overlay panel Eduard Tolosa a b , Teresa Botta-Orfila c d , Xavier Morató
e f , Carles Calatayud g , Raquel Ferrer-Lorente h i , María-José Martí a b , Manel Fernández …

Recent evidence indicates that specific RNAs promote the formation of ribonucleoprotein
condensates by acting as scaffolds for RNA-binding proteins (RBPs). We systematically …

… A Student's t-test was performed to assess for significant differences of RNA decay rate …
level with a 0.63 and 0.5 fold-change respectively (Student's t-test, P-value < 0.01, Figure 5A–C). …

… Teresa Botta-Orfila … *Ellen Gelpi and Teresa Botta-Orfila authors contributed equally to
this work. … *Ellen Gelpi and Teresa Botta-Orfila authors contributed equally to this work. …

… role of UC‐containing lncRNAs (T‐UCRs) in … T‐UCR expression profiles of undifferentiated
proliferating keratinocytes with those of differentiated keratinocytes (Fig 1A). We found 79 T‐…

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative
disorder manifesting in carriers of 55 to 200 CGG repeats in the 5′ untranslated region (UTR) …

Introduction The finding of mutations of the COQ2 gene and reduced coenzyme Q10 levels
in the cerebellum in multiple system atrophy (MSA) suggest that coenzyme Q10 is relevant to …

It has been reported that genes up-regulated in cancer are often down-regulated in
neurodegenerative disorders and vice versa. The fact that apparently unrelated diseases share …